Thermo Fisher Scientific Inc. (TMO) is a Medical pharmaceuticals company in the Healthcare sector, listed on New York Stock Exchange. This page provides the complete earnings calendar, dividend schedule, and financial data for Thermo Fisher Scientific Inc. in 2026. The next earnings report is expected on October 28, 2026. The upcoming ex-dividend date is September 15, 2026.
Next earnings date
28 Oct 2026
In 69 days
EPS estimate
6.37
Revenue estimate
12.0B
Past earnings
Latest earnings analysis
Thermo Fisher Scientific Inc. beat consensus estimates in its latest earnings report, with EPS of $6.03 coming in 5.4% above expectations and revenue of $11.99 billion exceeding estimates by 2.5%. In the prior quarter both EPS and revenue were also ahead of expectations.
Next ex-dividend
15 Sep 2026
In 26 days
Next payment
15 Oct 2026
In 56 days
Dividend amount
0.47
Frequency
Quarterly
Past dividends
| Ex-dividend | Payment | Amount |
|---|---|---|
| 15 Jun 2026 | 15 Jul 2026 | 0.47 |
| 13 Mar 2026 | 15 Apr 2026 | — |
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Thermo Fisher Scientific Inc. (TMO) is scheduled to report earnings on October 28, 2026.
Thermo Fisher Scientific Inc. (TMO) last reported earnings on July 23, 2026.
The next ex-dividend date for Thermo Fisher Scientific Inc. (TMO) is September 15, 2026, with a payment date of October 15, 2026.
Thermo Fisher Scientific Inc. (TMO) will pay a dividend of 0.47 per share.
Based on historical data, Thermo Fisher Scientific Inc. (TMO) pays dividends quarterly.
Thermo Fisher Scientific Inc. (TMO) is listed on New York Stock Exchange.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.